{"id":76607,"date":"2020-10-06T18:20:00","date_gmt":"2020-10-06T18:20:00","guid":{"rendered":"https:\/\/icrowdnewswire.com\/?p=2739059"},"modified":"2020-10-06T18:20:00","modified_gmt":"2020-10-06T18:20:00","slug":"global-peptide-synthesis-market-is-set-for-moderate-growth-to-reach-around-usd-474-3-million-by-2025","status":"publish","type":"post","link":"https:\/\/ipsnews.net\/business\/2020\/10\/06\/global-peptide-synthesis-market-is-set-for-moderate-growth-to-reach-around-usd-474-3-million-by-2025\/","title":{"rendered":"Global Peptide Synthesis Market Is Set For Moderate Growth, To Reach Around USD 474.3 Million by 2025"},"content":{"rendered":"

Zion Market Research has published a new report titled “Peptide Synthesis Market by Product (Equipment and Reagents); by Technology (Hybrid & Recombinant Technology, Liquid-phase Peptide Synthesis and Solid-phase Peptide Synthesis); for Contract Development & Manufacturing Organizations, Academic & Research Institutes and Pharmaceutical & Biotechnological Companies: Global Industry Perspective, Comprehensive Analysis and Forecast, 2018 – 2025”. According to the report, global demand for peptide synthesis market<\/a> was valued at approximately USD 294.5 million in 2018, and is expected to generate revenue of around USD 474.3 million by end of 2025, growing at a CAGR of around 7.1% between 2019 and 2025.<\/p>\n

Get Access to the FREE sample report @https:\/\/www.zionmarketresearch.com\/sample\/peptide-synthesis-market<\/a><\/span><\/span><\/strong><\/p>\n

\"Peptide<\/p>\n

Peptide production is referred as peptide synthesis. Peptide is a long sequence of multiple amino acids that are linked together via amide or peptide bonds. These peptides can be chemically manufactured synthetically by condensation reaction of the carboxyl group of one amino acid to the amino group of another. Chemical synthesis starts usually at C-terminus (carboxyl end) of one amino acid and proceeds towards N-terminus (amino terminus) opposite to what occurs in living organisms.<\/p>\n

The global peptide synthesis market growth is fueled by various factors like rising use of peptides in pharmaceutical drug development, development of advanced peptide synthesizers, availability of funding for R&D and increase in research activities. Also, growth is supported by increasing novel therapeutic peptide development projects, high unmet medical needs and increasing chronic disease burden. However, lack of amalgamated set of regulations may act as restraining factor that may limit the market growth during the forecast period. Emerging markets such as India and China with booming biopharmaceutical industry are projected to open new opportunities for peptide synthesis market.<\/p>\n

The peptide synthesis market is segmented based on technology, end user, product, and region. Based on product, market is segmented into reagents and equipment. In 2018, reagents product segment dominated the market owing to frequent and continuous use of reagents for routine peptide development studies and research. Fastest growth is projected for equipment segment over the forecast period. Technological advancements and production process optimization using advanced equipment and large volume production attribute to the fast growth of equipment segment. Chromatography equipment, lyophilizers, and peptide synthesizers are sub-segments of equipment product segment.<\/p>\n

Based on technology, global peptide synthesis market is segmented into liquid-phase peptide synthesis, hybrid and recombinant technology and solid-phase peptide synthesis. Solid-phase peptide synthesis technology is widely used due to various advantages like easy and inexpensive scale-up, large volume and high-quality peptide production. Rapid growth is projected for hybrid and recombinant technology over the forecast period due to swift growth in biopharmaceutical industry.<\/p>\n

Contract development and manufacturing organizations, pharmaceutical & biotechnological companies and academic & research institutes are end users of the market. Pharmaceutical & biotechnological companies held largest market share in 2018 owing to increasing investments for novel therapeutic peptide development by major pharmaceutical and biopharmaceutical companies.<\/p>\n

At regional level, North America held dominating revenue share in 2018 for the global peptide synthesis market. This large share is attributed to availability of developed R&D infrastructure, presence of major manufacturers, availability of funds, increasing chronic disease burden like cancer, obesity, diabetes etc., and technological advancements. Europe held second largest market share. Increasing R&D expenditure for novel peptide therapeutic development and presence of technologically advanced R&D infrastructure are factors likely to fuel market growth in this region. Latin America is projected to witness moderate growth during the forecast period. Asia Pacific region will exhibit fastest growth rate over the forecast period for peptide synthesis market. Increasing prevalence of chronic diseases like diabetes, cancer, infectious diseases etc., maturing pharmaceutical and biopharmaceutical industry in the emerging countries like India and China, along with government funding are projected to be market growth boosting in the coming years. Middle East and Africa will witness slow growth over the forecast period due to poor R&D infrastructure and lack of funds.<\/p>\n

Major players included in the report are GenScript Biotech Corporation, AAPPTec, Bachem, AnaSpec, Biotage, CEM Corporation, Gyros Protein Technologies, New England Peptide, Merck KGaA and Advanced ChemTech among others.<\/p>\n

The report segment of global peptide synthesis market as follows:<\/strong><\/p>\n

Global Peptide Synthesis<\/strong>Market<\/strong>:<\/strong>Product<\/strong><\/p>\n